DAPTOMYCIN and EOSINOPHILIA

Overview

EOSINOPHILIA is the #7 most commonly reported adverse reaction for DAPTOMYCIN, manufactured by APOTEX CORP.. There are 328 FDA adverse event reports linking DAPTOMYCIN to EOSINOPHILIA. This represents approximately 2.3% of all 14,068 adverse event reports for this drug.

Patients taking DAPTOMYCIN who experience eosinophilia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

EOSINOPHILIA is a less commonly reported adverse event for DAPTOMYCIN, but still significant enough to appear in the safety profile.

Other Side Effects of DAPTOMYCIN

In addition to eosinophilia, the following adverse reactions have been reported for DAPTOMYCIN:

• DRUG INEFFECTIVE — 703 reports
• OFF LABEL USE — 652 reports
• ACUTE KIDNEY INJURY — 527 reports
• PYREXIA — 459 reports
• EOSINOPHILIC PNEUMONIA — 418 reports
• RHABDOMYOLYSIS — 336 reports
• BLOOD CREATINE PHOSPHOKINASE INCREASED — 327 reports
• DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS — 322 reports
• NEUTROPENIA — 270 reports
• RASH — 255 reports

Does DAPTOMYCIN cause EOSINOPHILIA?

EOSINOPHILIA has been reported as an adverse event in 328 FDA reports for DAPTOMYCIN. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is EOSINOPHILIA with DAPTOMYCIN?

EOSINOPHILIA accounts for approximately 2.3% of all adverse event reports for DAPTOMYCIN, making it a notable side effect.

What should I do if I experience EOSINOPHILIA while taking DAPTOMYCIN?

If you experience eosinophilia while taking DAPTOMYCIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages